| NCT Number | NCT07382778 |
| Lead Sponsor | JW Pharmaceutical |
| Conditions | Hypercholesterolemia |
| Enrollment | 1,538 participants |
| Start Date | 2022-10-19 |
| Primary Completion | 2025-06-13 (estimated) |
| Study Completion | 2025-06-13 (estimated) |
| Updated on ClinicalTrials.gov | 2026-02-03 |